AATec Medical Secures EUR 4 Million to Advance Lead Respiratory Drug Candidate to Clinical Development
Funding from SPRIND and Family Offices accelerates preparation of ATL-105 for clinical development in lead indication non-CF related bronchiectasis by 2026 Munich, Germany – 15.0
AATec Medical Welcomes Professor James Chalmers to Scientific Advisory Board
Leading Expert in Respiratory Medicine Supporting AATec in Product Development in Non-CF Bronchiectasis Munich, Germany – 18.09.2024 – AATec Medical GmbH (AATec), a biotech com